Global POCT Chemiluminescence Immunoassay(CLIA) Analyzer Market Growth 2025-2031
Description
The global POCT Chemiluminescence Immunoassay(CLIA) Analyzer market size is predicted to grow from US$ 2979 million in 2025 to US$ 4681 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.
The POCT chemiluminescent immunoassay analyzer is a device for performing chemiluminescence immunoassay. It combines chemiluminescence technology and immunological analysis methods and can be used to quickly detect biomarkers in body fluids, such as hormones, tumor markers, infectious disease markers, etc.
Major players in the global POCT chemiluminescent immunoassay analyzer market include internationally renowned companies such as Roche Diagnostics, Abbott, Beckman Coulter, and Siemens Healthcare. Globally, the top five manufacturers account for about 80% of the market share, showing a high brand concentration.
As for the region, North America is the largest consumption region, holding 40% market share in 2023.
The market for POCT Chemiluminescence Immunoassay Analyzers is potential market for growth as it be applied in various fields within Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease, etc. Among various applications, demand from Oncology is the largest one.
In 2023, Fully Automated Chemiluminescence Immunoassay Analyzers accounted for a major share of 65% the global Chemiluminescence Immunoassay Analyzers market.
Market trends and opportunities
Technological innovation: With the continuous development of science and technology, the sensitivity and specificity of POCT chemiluminescent immunoassay analyzers have been continuously improved, and the operation has become easier, which has promoted the rapid growth of the market. In the future, technological innovation will continue to lead the development of the market.
Aging population: The global aging trend is intensifying, and the demand for chronic diseases and disease screening is increasing, which provides a broad development space for the POCT chemiluminescent immunoassay analyzer market.
The rise of emerging markets: The rapid economic development of emerging markets such as the Asia-Pacific region and the Middle East, the improvement of medical care levels, and the increasing demand for high-end medical equipment have brought new growth opportunities to the market.
LP Information, Inc. (LPI) ' newest research report, the “POCT Chemiluminescence Immunoassay(CLIA) Analyzer Industry Forecast” looks at past sales and reviews total world POCT Chemiluminescence Immunoassay(CLIA) Analyzer sales in 2024, providing a comprehensive analysis by region and market sector of projected POCT Chemiluminescence Immunoassay(CLIA) Analyzer sales for 2025 through 2031. With POCT Chemiluminescence Immunoassay(CLIA) Analyzer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Chemiluminescence Immunoassay(CLIA) Analyzer industry.
This Insight Report provides a comprehensive analysis of the global POCT Chemiluminescence Immunoassay(CLIA) Analyzer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Chemiluminescence Immunoassay(CLIA) Analyzer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POCT Chemiluminescence Immunoassay(CLIA) Analyzer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Chemiluminescence Immunoassay(CLIA) Analyzer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Chemiluminescence Immunoassay(CLIA) Analyzer.
This report presents a comprehensive overview, market shares, and growth opportunities of POCT Chemiluminescence Immunoassay(CLIA) Analyzer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Semi-Automated
Fully Automated
Segmentation by Application:
Hospital
Clinic
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott
Siemens Healthcare
Ortho Clinical Diagnostics
Beckman Coulter
Snibe
DiaSorin
Maccura Biotechnology
Tosoh Bioscience
Sysmex
Beijing Leadman Biochemis
Mindray
Autobio Diagnostics
Key Questions Addressed in this Report
What is the 10-year outlook for the global POCT Chemiluminescence Immunoassay(CLIA) Analyzer market?
What factors are driving POCT Chemiluminescence Immunoassay(CLIA) Analyzer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do POCT Chemiluminescence Immunoassay(CLIA) Analyzer market opportunities vary by end market size?
How does POCT Chemiluminescence Immunoassay(CLIA) Analyzer break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The POCT chemiluminescent immunoassay analyzer is a device for performing chemiluminescence immunoassay. It combines chemiluminescence technology and immunological analysis methods and can be used to quickly detect biomarkers in body fluids, such as hormones, tumor markers, infectious disease markers, etc.
Major players in the global POCT chemiluminescent immunoassay analyzer market include internationally renowned companies such as Roche Diagnostics, Abbott, Beckman Coulter, and Siemens Healthcare. Globally, the top five manufacturers account for about 80% of the market share, showing a high brand concentration.
As for the region, North America is the largest consumption region, holding 40% market share in 2023.
The market for POCT Chemiluminescence Immunoassay Analyzers is potential market for growth as it be applied in various fields within Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease, etc. Among various applications, demand from Oncology is the largest one.
In 2023, Fully Automated Chemiluminescence Immunoassay Analyzers accounted for a major share of 65% the global Chemiluminescence Immunoassay Analyzers market.
Market trends and opportunities
Technological innovation: With the continuous development of science and technology, the sensitivity and specificity of POCT chemiluminescent immunoassay analyzers have been continuously improved, and the operation has become easier, which has promoted the rapid growth of the market. In the future, technological innovation will continue to lead the development of the market.
Aging population: The global aging trend is intensifying, and the demand for chronic diseases and disease screening is increasing, which provides a broad development space for the POCT chemiluminescent immunoassay analyzer market.
The rise of emerging markets: The rapid economic development of emerging markets such as the Asia-Pacific region and the Middle East, the improvement of medical care levels, and the increasing demand for high-end medical equipment have brought new growth opportunities to the market.
LP Information, Inc. (LPI) ' newest research report, the “POCT Chemiluminescence Immunoassay(CLIA) Analyzer Industry Forecast” looks at past sales and reviews total world POCT Chemiluminescence Immunoassay(CLIA) Analyzer sales in 2024, providing a comprehensive analysis by region and market sector of projected POCT Chemiluminescence Immunoassay(CLIA) Analyzer sales for 2025 through 2031. With POCT Chemiluminescence Immunoassay(CLIA) Analyzer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Chemiluminescence Immunoassay(CLIA) Analyzer industry.
This Insight Report provides a comprehensive analysis of the global POCT Chemiluminescence Immunoassay(CLIA) Analyzer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Chemiluminescence Immunoassay(CLIA) Analyzer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POCT Chemiluminescence Immunoassay(CLIA) Analyzer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Chemiluminescence Immunoassay(CLIA) Analyzer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Chemiluminescence Immunoassay(CLIA) Analyzer.
This report presents a comprehensive overview, market shares, and growth opportunities of POCT Chemiluminescence Immunoassay(CLIA) Analyzer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Semi-Automated
Fully Automated
Segmentation by Application:
Hospital
Clinic
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott
Siemens Healthcare
Ortho Clinical Diagnostics
Beckman Coulter
Snibe
DiaSorin
Maccura Biotechnology
Tosoh Bioscience
Sysmex
Beijing Leadman Biochemis
Mindray
Autobio Diagnostics
Key Questions Addressed in this Report
What is the 10-year outlook for the global POCT Chemiluminescence Immunoassay(CLIA) Analyzer market?
What factors are driving POCT Chemiluminescence Immunoassay(CLIA) Analyzer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do POCT Chemiluminescence Immunoassay(CLIA) Analyzer market opportunities vary by end market size?
How does POCT Chemiluminescence Immunoassay(CLIA) Analyzer break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
125 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for POCT Chemiluminescence Immunoassay(CLIA) Analyzer by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for POCT Chemiluminescence Immunoassay(CLIA) Analyzer by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
